Why will Biosensor Sales Boom in Asia-Pacific in Coming Years?

 The global biosensors market size is anticipated to reach USD 33.76 billion by 2026 registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc.

Various applications in the medical field, high demand for miniature diagnostic devices, and rapid technological advancements are the key driving factors for biosensors market growth.

Early and precise disease diagnosis is essential for successful prognosis of diseases and survival of patients.

In recent years, the demand for simple, disposable, user-friendly, and cost-efficient devices with fast response time has increased extensively leading to increase in the sales of these products, thereby driving the market.Continuous technological developments are also expected to boost the market.

For instance, in October 2015, Abbott Laboratories launched FreeStyle Libre Glucose Monitoring System in Europe.

It is intended to be a replacement for blood glucose meters.

The increasing demand for miniaturized connectors, expanding medical devices industry, surging aging population, and rising prevalence of chronic diseases are some of the major reasons behind for the prosperity of the medical connectors market.

In 2016, the market attained a size of $1.9 billion, and it is projected to generate a revenue of $2.8 billion by 2023, progressing at a CAGR of 6.3% during the forecast period (2017–2023).

Medical connectors are used to latch or un-latch the tubing in medical devices and connect such devices and systems for transferring signals, data, media or power.Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/medical-connector-market/report-sampleBased on product, the medical connectors market is broadly categorized into board-to-board, push-pull, radio-frequency, input/output (I/O) rectangular, and disposable plastic.

Out of these, in 2016, board-to-board connectors dominated the market with a revenue contribution of $725.8 million, and these are predicted to continue dominating it during the forecast period.

This is attributed to the fact that these connectors comply with strict safety standards, such as prevention of inadvertent plug disengagement, and have a better shock rating.Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-connector-marketSimilarly, as per the World Bank, in 2012, in the U.S., 30,537 surgeries were done per 100,000 population.

In 2015, the number of surgical procedures done in Australia was 28,907 per 100,000 population.

Automation is defined as the use of control systems and information technologies to reduce the need for human work in the production of goods and services.

Now automation surrounds us every day in our lives, including automated teller machines (ATMs), Redbox DVD rentals, self-checkout at the grocery store, cellphone-controlled thermostats, auto park assist in vehicles, and many more routine activities managed by technology.

Despite its use for years in banking, retail and other industries, healthcare has lagged behind in its use of automation.

And that has brought the adoption of automation to the spotlight.Lately, different mechanical headways prompted the automation of the healthcare sector which has empowered the controlled utilization of healthcare systems and related innovations.

Expanding pervasiveness of chronic diseases like diabetes, cancer and others alongside the developing pharmaceutical and biotechnology industry are the significant drivers for the market development of the global medical automation market amid the forecast period.

Based on its end users, the market is sectioned into pharmacies, research labs & institutes, hospitals, and diagnostic centers, research labs & institutes, among others.

Global Healthcare Biosensors IoT Market size was valued over USD 17 billion in 2017 and is expected to witness growth of ~8% CAGR from 2018 to 2024.

For instance, newly developed glucometers have embedded microchips that allows accurate and quick detection of sugar levels at home.

Biosensors for measuring blood metabolites such as lactate, glucose, creatinine, and urea, using both optical and electrochemical modes of transduction, are being routinely used and commercially developed in the point of care testing, laboratories, and for self-testing in the case of glucose monitoring.

Biosensors have applications in various segments in the healthcare industry.

Extended use of biosensors in various industries such as medical diagnostics, agricultural and food diagnostic industry has stimulated the demand for biosensors.

Significant funding is been made in Europe by Max-Planck Institute in collaboration with the Federal Government of Germany and other German states.

Bio decontamination is largely defined as the process of neutralization as well as the removal of infectious microorganisms, chemical agents and radioactive materials.

What the Biological Decontamination Market Looks Like?

The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% Pharmaceuticals and Medical Devices Companies: On the basis of end user, the biodecontamination market is segmented into pharmaceutical & medical device manufacturing companies, hospitals & healthcare facilities, and life sciences & biotechnology research organizations.

In 2018, the pharmaceutical & medical device manufacturing companies segment accounted for the largest market share and highest growth rate, owing to the growing adoption of biodecontamination products & services by pharmaceutical and medical device manufacturing industries to adhere to stringent regulations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Key Factors Driving Growth in Bio Decontamination Industry: 1.

Increasing Number of Surgical Procedures 3.

The Biosensors Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the biosensors market includes Abbott Laboratories, AZUR Environmental, Bayer AG, Biosensor BV, Cranfield Biotechnology Centre, DuPont Biosensor Materials, EG & IC Sensors, Inc., Ercon, Inc., Innovative Biosensors Inc., Johnson & Johnson, LifeScan, Inc., Molecular Devices Corp., Pinnacle Technologies Inc., QTL Biosystems, Roche Diagnostics, Strategic Diagnostics and Sysmex Corporation.

An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Biosensors Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/biosensors-market/download-sampleMarket DynamicsRising geriatric population coupled with increase in demand for diagnosis of various chronic diseases is driving the market growth.

Rising patient preference towards point of care testing is likely to fuel the market growth.

Increasing demand for inexpensive, user-friendly and accurate diagnosis providing devices is likely to spur the market demand in clinics, hospitals and other end-user industries.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.